title: Does sulphinpyrazone reduce haemolysis from prosthetic heart valves?
authors.affiliation: Department of Medical Radiology, Royal Infirmary, Edinburgh, Scotland.
authors.forename: M
authors.initials: M
authors.lastname: Errington
authors.forename: P
authors.initials: P
authors.lastname: Bloomfield
mesh_terms: D000368:Aged; D000743:Anemia, Hemolytic / Q000188:drug therapy / Q000209:etiology; D001705:Bioprosthesis / Q000009:adverse effects; D005260:Female; D006350:Heart Valve Prosthesis / Q000009:adverse effects; D006461:Hemolysis / Q000187:drug effects*; D006801:Humans; D008297:Male; D008875:Middle Aged; D013442:Sulfinpyrazone / Q000627:therapeutic use*
chemical_list: D013442:Sulfinpyrazone